Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | OT |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | OT |
The patient then reported that she "had a weird rash" on her arm in which the vaccines were injected.; This spontaneous report was received from a Nurse and refers to an "older" female patient of unknown age. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), along with shingles vaccine (manufacturer unknown) (lot #, expiration date, strength, dose number, route of administration, anatomical location not provided) as prophylaxis. On an unknown date, the patient reported that she "had a weird rash" on her arm in which the vaccines were injected. The reporter did not see the rash the patient reported the event by phone, and she did not seek medical assistance. At the reporting time, the outcome of vaccination site rash was unknown. The causal relationship between the event and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), and shingles vaccine (manufacturer unknown) was not reported.